A W Goddard

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder
    A W Goddard
    Yale University Department of Psychiatry, Connecticut Mental Health Center, New Haven 06519, USA
    Psychiatry Res 85:225-40. 1999
  2. ncbi Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy
    A W Goddard
    Yale Anxiety Clinic, Yale Department of Psychiatry, 100 York St, Room 2J, New Haven, CT 06511, USA
    Arch Gen Psychiatry 58:556-61. 2001
  3. ncbi Early coadministration of clonazepam with sertraline for panic disorder
    A W Goddard
    Department of Psychiatry, Yale University School of Medicine, and Yale Anxiety Clinic, 100 York St 2J, New Haven, CT 06511, USA
    Arch Gen Psychiatry 58:681-6. 2001
  4. ncbi Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients
    G M Asnis
    Department of Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center, 111 E 210th Street, Bronx, New York, NY 10467 2490, USA
    Psychiatry Res 103:1-14. 2001
  5. ncbi Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders
    J H Krystal
    Department of Psychiatry, Yale University School of Medicine, Connecticut, USA
    Med Clin North Am 85:559-77. 2001
  6. ncbi Linkage genome scan for loci predisposing to panic disorder or agoraphobia
    J Gelernter
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue, West Haven, CT 06516, USA
    Am J Med Genet 105:548-57. 2001
  7. ncbi Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions
    S W Woods
    Connecticut Mental Health Center, Yale University School of Medicine Department of Psychiatry, New Haven 06508, USA
    Am J Psychiatry 155:1446-8. 1998

Detail Information

Publications7

  1. ncbi Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder
    A W Goddard
    Yale University Department of Psychiatry, Connecticut Mental Health Center, New Haven 06519, USA
    Psychiatry Res 85:225-40. 1999
    ..However, follow-up studies using higher doses of CI-988 are indicated to confirm this preliminary finding as are studies more closely evaluating the interrelationship between CCK and 5-HT function in GAD...
  2. ncbi Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy
    A W Goddard
    Yale Anxiety Clinic, Yale Department of Psychiatry, 100 York St, Room 2J, New Haven, CT 06511, USA
    Arch Gen Psychiatry 58:556-61. 2001
    ..The purpose of the present work was to determine whether cortical GABA levels are abnormally low in patients with panic disorder...
  3. ncbi Early coadministration of clonazepam with sertraline for panic disorder
    A W Goddard
    Department of Psychiatry, Yale University School of Medicine, and Yale Anxiety Clinic, 100 York St 2J, New Haven, CT 06511, USA
    Arch Gen Psychiatry 58:681-6. 2001
    ..The purpose of this study was to test the efficacy of early coadministration of clonazepam with sertraline in the treatment of panic disorder...
  4. ncbi Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients
    G M Asnis
    Department of Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center, 111 E 210th Street, Bronx, New York, NY 10467 2490, USA
    Psychiatry Res 103:1-14. 2001
    ..Significant improvement was evident as early as week 1 for some panic variables. Fluvoxamine is a potent anti-panic agent with a relatively rapid onset of action...
  5. ncbi Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders
    J H Krystal
    Department of Psychiatry, Yale University School of Medicine, Connecticut, USA
    Med Clin North Am 85:559-77. 2001
    ..The current era is an exciting one for psychiatric research and the rapidity with which advances are being made is a source of hope to patients with these disorders and for society...
  6. ncbi Linkage genome scan for loci predisposing to panic disorder or agoraphobia
    J Gelernter
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue, West Haven, CT 06516, USA
    Am J Med Genet 105:548-57. 2001
    ..Overall, the results presented here suggest that PD and agoraphobia are complex traits that share some, but not all, of their susceptibility loci. Published 2001 Wiley-Liss, Inc...
  7. ncbi Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions
    S W Woods
    Connecticut Mental Health Center, Yale University School of Medicine Department of Psychiatry, New Haven 06508, USA
    Am J Psychiatry 155:1446-8. 1998
    ..The authors propose that it may be more efficient to allocate unequal proportions of the total sample size to treatments when more than two treatments are being compared...